Cellectis SA
PAR:ALCLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cellectis SA
PAR:ALCLS
|
FR |
|
Sequans Communications SA
NYSE:SQNS
|
FR |
|
N
|
Novo Nordisk A/S
XBER:NOVA
|
DK |
|
A
|
Actic Group AB
LSE:0ROI
|
SE |
|
I
|
IGM Financial Inc
F:C7G
|
CA |
|
A
|
Atos SE
DUS:AXI
|
FR |
|
F
|
Fraport AG Frankfurt Airport Services Worldwide
XBER:FRA
|
DE |
Wall St Price Targets
ALCLS Price Targets Summary
Cellectis SA
According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALCLS's stock price target?
Price Target
6.63
EUR
According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.
What is the Revenue forecast for Cellectis SA?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 7 years is 21%.
What is the Gross Profit forecast for Cellectis SA?
Projected CAGR
162%
The compound annual growth rate for Gross Profit over the next 1 year is 162%.
